BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35440034)

  • 1. Comparison of platinum monotherapy with concurrent chemoradiation therapy versus platinum-based dual drug therapy with concurrent chemoradiation therapy for locally advanced cervical cancer: a systematic review and meta-analysis.
    Deng T; Gu S; Wu J; Yu Y
    Infect Agent Cancer; 2022 Apr; 17(1):18. PubMed ID: 35440034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of consolidation chemotherapy after concurrent chemoradiation on the prognosis of locally advanced cervical cancer: a systematic review and meta-analysis.
    Zhong L; Li K; Song L; Yin R
    J Obstet Gynaecol; 2022 Jul; 42(5):830-837. PubMed ID: 35148230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent chemoradiotherapy followed by adjuvant chemotherapy versus concurrent chemoradiotherapy alone in locally advanced cervical cancer: A systematic review and meta-analysis.
    Liu H; Ma X; Sun C; Wu M; Xu Z; Zhou S; Yao N; Liu S; Qin X; Han Z
    Front Oncol; 2022; 12():997030. PubMed ID: 36568251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: A systematic review and meta-analysis.
    Tan TH; Soon YY; Cheo T; Ho F; Wong LC; Tey J; Tham IWK
    Radiother Oncol; 2018 Oct; 129(1):10-17. PubMed ID: 29555182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis.
    Zhou R; Zhu J; Chen X; Liu Y; Wang Y; Zhang T
    Clin Transl Oncol; 2020 Mar; 22(3):429-439. PubMed ID: 31165410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum single-agent vs. platinum-based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer: A meta-analysis of randomized controlled trials.
    Ma S; Wang J; Han Y; Guo F; Chen C; Chen X; Zou W
    Gynecol Oncol; 2019 Jul; 154(1):246-252. PubMed ID: 31005286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy.
    Wu N; Su X; Song H; Li Y; Gu F; Sun X; Li X; Cheng G
    Cancer Control; 2021; 28():1073274821989307. PubMed ID: 33593091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoradiotherapy with hyperthermia versus chemoradiotherapy alone in locally advanced cervical cancer: a systematic review and meta-analysis.
    Yea JW; Park JW; Oh SA; Park J
    Int J Hyperthermia; 2021; 38(1):1333-1340. PubMed ID: 34477028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant and Adjuvant Treatments Compared to Concurrent Chemoradiotherapy for Patients With Locally Advanced Cervical Cancer: A Bayesian Network Meta-Analysis.
    Qiao Y; Li H; Peng B
    Front Oncol; 2022; 12():745522. PubMed ID: 35372073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adjuvant chemotherapy after concurrent chemoradiotherapy in patients with locally advanced cervical cancer.
    Kou L; Zhang T; Yang X; Peng S; Wang Y; Yuan M; Li M
    Future Oncol; 2022 May; 18(16):1917-1915. PubMed ID: 35193379
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of nimotuzumab combined with chemoradiotherapy in the treatment of locally advanced cervical cancer.
    Zhang L; Jiang Y; Jiang P; Chen Z; Cui H; Zhang Y
    Ann Transl Med; 2022 Dec; 10(24):1322. PubMed ID: 36660627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy (with or without Chemotherapy) in Patients with Stage IB2, IIA, or IIB Cervical Cancer: A Systematic Review and Meta-Analysis.
    Ye Q; Yang Y; Tang X; Li J; Li X; Zhang Y
    Dis Markers; 2020; 2020():7415056. PubMed ID: 32802215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment Plasma EBV-DNA Load Guides Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Cancer: A Meta-Analysis.
    Lai L; Chen X; Zhang C; Chen X; Chen L; Tian G; Zhu X
    Front Oncol; 2020; 10():610787. PubMed ID: 33665166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradiotherapy alone vs. chemoradiotherapy and hysterectomy for locally advanced cervical cancer: A systematic review and updated meta-analysis.
    Lu W; Lu C; Yu Z; Gao L
    Oncol Lett; 2021 Feb; 21(2):160. PubMed ID: 33552278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of outcomes and side effects for neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation vs. chemoradiation alone in stage IIB-IVA cervical cancer: study protocol for a randomized controlled trial.
    Li J; Liu H; Li Y; Li J; Shen L; Long W; Yang C; Xu H; Xi W; Cai R; Feng W
    Trials; 2022 Jan; 23(1):29. PubMed ID: 35012634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non-Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical Trial.
    Bi N; Liang J; Zhou Z; Chen D; Fu Z; Yang X; Feng Q; Hui Z; Xiao Z; Lv J; Wang X; Zhang T; Wang X; Deng L; Wang W; Wang J; Liu L; Hu C; Wang L
    JAMA Netw Open; 2019 Dec; 2(12):e1918070. PubMed ID: 31851351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of concurrent chemoradiotherapy with induction chemotherapy
    Liu Y; Yang L; Zhang S; Lin B
    Transl Cancer Res; 2022 May; 11(5):1207-1218. PubMed ID: 35706809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Survival in Nonsurgical Esophageal Cancer Patients Who Received Consolidation Chemotherapy Compared With Patients Who Received Concurrent Chemoradiotherapy Alone: A Systematic Review and Meta-Analysis.
    Xia X; Liu Z; Qin Q; Di X; Zhang Z; Sun X; Ge X
    Front Oncol; 2020; 10():604657. PubMed ID: 33489910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancer.
    Kong TW; Chang SJ; Paek J; Yoo SC; Yoon JH; Chang KH; Chun M; Ryu HS
    J Gynecol Oncol; 2012 Oct; 23(4):235-41. PubMed ID: 23094126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-utility analysis of adjuvant chemotherapy after concurrent chemoradiation in patients with locally advanced cervical cancer.
    Rongsriyam K; Tangjitgamol S; Leelahavarong P; Teerawattananon Y; Tharavichitkul E; Tovanabutra C; Asakij T; Paengchit K; Sukhaboon J; Penpattanagul S; Kridakara LCA; Hanprasertpong J; Khunnarong J; Chottetanaprasith T; Lorvidhaya V
    J Med Imaging Radiat Oncol; 2020 Dec; 64(6):873-881. PubMed ID: 32978901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.